Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CENEGERMIN-BKBJ vs CERITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CENEGERMIN-BKBJ vs CERITINIB: Safety Overview

Metric CENEGERMIN-BKBJ CERITINIB
Total FAERS Reports 11,919 2,796
Deaths Reported 199 786
Death Rate 1.7% 28.1%
Hospitalizations 736 804
Average Patient Age 68.5 yrs 55.6 yrs
% Female Patients 70.3% 55.1%
FDA Approval Date N/A Apr 29, 2014
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status Prescription Discontinued